You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
Title |
Predictors of response to Infliximab in children with luminal Crohn's disease☆
|
---|---|
Published in |
Journal of Crohn's and Colitis Supplements, January 2014
|
DOI | 10.1016/j.crohns.2013.12.017 |
Pubmed ID | |
Authors |
Zubin Grover, Rebecca Biron, Nicholas Carman, Peter Lewindon |
Abstract |
A significant proportion of patients with initial response to Inflximab (IFX), subsequently lose response (LOR). Multicentre paediatric studies report LOR in 33% to 50% with 3-5year follow-up. Our retrospective study examined durability of response and predictors of LOR. |
X Demographics
The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 50% |
Unknown | 1 | 50% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 2 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 69 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Canada | 1 | 1% |
Unknown | 68 | 99% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 16 | 23% |
Student > Ph. D. Student | 9 | 13% |
Other | 6 | 9% |
Student > Postgraduate | 5 | 7% |
Professor > Associate Professor | 5 | 7% |
Other | 13 | 19% |
Unknown | 15 | 22% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 36 | 52% |
Agricultural and Biological Sciences | 3 | 4% |
Computer Science | 2 | 3% |
Biochemistry, Genetics and Molecular Biology | 1 | 1% |
Nursing and Health Professions | 1 | 1% |
Other | 3 | 4% |
Unknown | 23 | 33% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 August 2014.
All research outputs
#17,285,036
of 25,373,627 outputs
Outputs from Journal of Crohn's and Colitis Supplements
#1,492
of 2,103 outputs
Outputs of similar age
#202,356
of 320,591 outputs
Outputs of similar age from Journal of Crohn's and Colitis Supplements
#28
of 43 outputs
Altmetric has tracked 25,373,627 research outputs across all sources so far. This one is in the 21st percentile – i.e., 21% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,103 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 12.1. This one is in the 19th percentile – i.e., 19% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 320,591 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 27th percentile – i.e., 27% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 43 others from the same source and published within six weeks on either side of this one. This one is in the 27th percentile – i.e., 27% of its contemporaries scored the same or lower than it.